Ibrahim Aldoss, MD, discusses the potential of AZD0486 for treating relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) and outlines the SYRUS study objectives. AZD0486 is a novel IgG ...
This article was republished with permission from WTOP’s news partners at Maryland Matters. Sign up for Maryland Matters’ free email subscription today. This content was republished with permission ...
Maryland is among the top 10 states where residents are most often searching online for lawyers, according to research conducted by a Texas personal injury firm. The study analyzed which states had ...
Hosted on MSN
B-cell lymphoma study identifies traits tied to greatest benefit from CD19 CAR T cell therapy
In the largest study of its kind, researchers from The University of Texas MD Anderson Cancer Center identified three subgroups of patients with large B-cell lymphoma (LBCL) who have different levels ...
A study at The University of Texas MD Anderson Cancer Center demonstrated how a small molecule drug discovered at the institution may help overcome resistance to treatment with ibrutinib in patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results